Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 11 citations · 14 references
MedicineHematologyOncologyHematologic OncologyHematopathologyMolecular OncologyBone Marrow EvaluationBone Marrow PathologyHematologic MalignanciesHla TypingAcute LeukemiasAcute Promyelocytic LeukemiaCancer Mortality RatesHla Antigen ExpressionLeukemia PathologyMortality RatesOverall MortalityPrognostic Factors Analysis
In order to explore the prognostic value of CD2, CD4, and human leucocyte antigen-DR (HLA-DR) expression and Fms-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) mutation in leukemia cells in the bone marrow of patients with acute promyelocytic leukemia (APL), we retrospectively collected and analyzed the immunophenotype, molecular features and clinical characteristics of 219 newly diagnosed adult patients with APL in Henan Provincial People's Hospital from January 2010 to December 2019. It turned out that the relapse rates of patients with CD2, CD4, or HLA-DR expression and the early mortality rates of patients with CD2 expression, HLA-DR expression, or FLT3-ITD mutation were higher than those of their counterparts. Moreover, reduced overall survival was found for patients who showed CD2 expression, HLA-DR expression or FLT3-ITD mutation. Therefore, CD2 expression, HLA-DR expression and FLT3-ITD mutation were adverse prognostic factors in adults with APL.
14
Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid
Jae H. Park, Baozhen Qiao, Katherine S. Panageas et al. · Blood · 2011 · 420 citations · Full text
Life Sciences, Hematology, Oncology +11
Pau Montesinos, Juan Bergua, Edo Vellenga et al. · Blood · 2008 · 364 citations · Full text
Medicine, Hematology, Oncology +17
Antonio R. Lucena‐Araujo, Haesook T. Kim, Rafael Henriques Jácomo et al. · Annals of Hematology · 2014 · 75 citations